Literature DB >> 16424542

Ophthalmic pathology of genotypically confirmed von Hippel Lindau disease type 1.

C M Knapp, G Woodruff, F Roberts.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16424542      PMCID： PMC1860170          DOI： 10.1136/bjo.2005.079152

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.

Authors:  D Glavac; H P Neumann; C Wittke; H Jaenig; O Masek; T Streicher; F Pausch; D Engelhardt; K H Plate; H Höfler; F Chen; B Zbar; H Brauch
Journal:  Hum Genet       Date:  1996-09       Impact factor: 4.132

2.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

3.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

4.  Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.

Authors:  Hélène Dollfus; Pascale Massin; Pierre Taupin; Catherine Nemeth; Sandrine Amara; Sophie Giraud; Christophe Béroud; Pascal Dureau; Alain Gaudric; Paul Landais; Stéphane Richard
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

5.  The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations.

Authors:  D Wittebol-Post; F J Hes; C J Lips
Journal:  J Intern Med       Date:  1998-06       Impact factor: 8.989

6.  Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.

Authors:  F Chen; T Kishida; M Yao; T Hustad; D Glavac; M Dean; J R Gnarra; M L Orcutt; F M Duh; G Glenn
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

7.  von Hippel-Lindau disease: angiomatosis of the retina and central nervous system.

Authors:  G L Wing; J J Weiter; P J Kelly; D M Albert; J R Gonder
Journal:  Ophthalmology       Date:  1981-12       Impact factor: 12.079

Review 8.  Clinical features and molecular genetics of Von Hippel-Lindau disease.

Authors:  E R Maher; A R Webster; A T Moore
Journal:  Ophthalmic Genet       Date:  1995-09       Impact factor: 1.803

9.  Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

Authors:  P A Crossey; F M Richards; K Foster; J S Green; A Prowse; F Latif; M I Lerman; B Zbar; N A Affara; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

10.  Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.

Authors:  B R Seizinger; G A Rouleau; L J Ozelius; A H Lane; G E Farmer; J M Lamiell; J Haines; J W Yuen; D Collins; D Majoor-Krakauer
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962
  10 in total
  1 in total

1.  Optical Coherence Tomography Findings of Exophytic Retinal Capillary Hemangiomas of the Posterior Pole.

Authors:  Eric K Chin; Rupan Trikha; Lawrence S Morse; Robert J Zawadzki; John S Werner; Susanna S Park
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.